Infinovo was formed in 2016. For the past few years, Infinovo has been focusing on developing an Accurate and Affordable CGM for patients which will be available for both Type 1 and Type 2 Diabetics. Our World Class Engineers have developed a CGM which can compete in the Global Market for Accuracy, Durability and Design. The Glunovo i3 CGM is the first-generation CGM product from Infinovo, and in the coming months will be available in the European Market. The Glunovo i3 is the first commercialised 14-day Realtime CGM, where the Transmitter can last 3 years, making this an Affordable option for all.